Search

  • Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Letter to the Editor
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • critical-appraisal
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • original-report
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • review-paper
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Immunohematology

 

Article | 16-October-2019

Hemovigilance and the Notify Library

secretions (e.g., breast milk) and excretions—all originating from the human body. Donated by a human with the goal of benefitting others, these MPHO have indeed saved and improved human lives through their clinical application. Vigilance is a powerful tool for improving safety and quality. Vigilance includes monitoring and reporting adverse events and outcomes associated with therapeutic treatments. Originating from hemovigilance for blood components, biovigilance is the term used for the monitoring of

B.I. Whitaker, D.M. Strong, M.J. Gandhi, E. Petrisli

Immunohematology, Volume 33 , ISSUE 4, 159–164

Report | 20-March-2020

The ARC Hemovigilance Program: advancing the safety of blood donation and transfusion

Anne F. Eder, Beth A. Dy, Jessica Barton, Jean M. Kennedy, Richard J. Benjamin

Immunohematology, Volume 25 , ISSUE 4, 179–185

Report | 16-March-2020

Transfusion of rare cryopreserved red blood cell units stored at -80°C: the French experience

through the French hemovigilance program, which requires a mandatory report of any transfusion reaction. It has recently been suggested to extend the 10-year restriction in some countries. Considering our experience and observational data, we may consider it safe and efficient to transfuse rare frozen RBC units older than 10 years. An international consensus for RBC cryopreservation time should ideally be established.

Thierry Peyrard, Bach-Nga Pham, Pierre-Yves Le Pennec, Philippe Rouger

Immunohematology, Volume 25 , ISSUE 1, 13–17

No Record Found..
Page Actions